tradingkey.logo

TELA Bio Inc

TELA
1.200USD
-0.090-6.98%
Cierre 11/05, 16:00ETCotizaciones retrasadas 15 min
47.50MCap. mercado
PérdidaP/E TTM

Más Datos de TELA Bio Inc Compañía

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

Información de TELA Bio Inc

Símbolo de cotizaciónTELA
Nombre de la empresaTELA Bio Inc
Fecha de salida a bolsaNov 08, 2019
Director ejecutivoMr. Antony Koblish
Número de empleados209
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 08
Dirección1 Great Valley Parkway, Suite 24
CiudadMALVERN
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal19355
Teléfono14843202930
Sitio Webhttps://www.telabio.com/
Símbolo de cotizaciónTELA
Fecha de salida a bolsaNov 08, 2019
Director ejecutivoMr. Antony Koblish

Ejecutivos de TELA Bio Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Betty Jo Rocchio
Betty Jo Rocchio
Independent Director
Independent Director
11.93K
--
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. William Plovanic
Mr. William Plovanic
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Por negocioUSD
Nombre
Ganancia
Proporción
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%

Estadísticas de accionistas

Actualizado: vie., 17 de oct
Actualizado: vie., 17 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
12.90%
EW Healthcare Partners
10.38%
North Run Capital, LP
9.30%
SilverArc Capital Management, LLC
7.02%
Lytton (Laurence W)
6.88%
Otro
53.53%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
12.90%
EW Healthcare Partners
10.38%
North Run Capital, LP
9.30%
SilverArc Capital Management, LLC
7.02%
Lytton (Laurence W)
6.88%
Otro
53.53%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
36.86%
Investment Advisor
10.66%
Venture Capital
10.38%
Investment Advisor/Hedge Fund
9.26%
Individual Investor
9.10%
Research Firm
2.12%
Otro
21.64%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
171
28.86M
72.85%
-9.81M
2025Q2
185
33.40M
84.44%
-6.87M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
5.11M
12.9%
-1.00
-0.00%
Jun 30, 2025
EW Healthcare Partners
4.11M
10.38%
--
--
Jun 30, 2025
North Run Capital, LP
3.68M
9.3%
+1.70M
+85.75%
Mar 31, 2025
SilverArc Capital Management, LLC
2.78M
7.02%
+8.51K
+0.31%
Jun 30, 2025
Lytton (Laurence W)
2.72M
6.88%
+271.93K
+11.09%
Jun 30, 2025
Stonepine Capital Management, LLC
2.08M
5.26%
+28.54K
+1.39%
Jun 30, 2025
The Vanguard Group, Inc.
1.91M
4.83%
-16.59K
-0.86%
Jun 30, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Jun 30, 2025
Perkins Capital Management, Inc.
875.87K
2.21%
-34.75K
-3.82%
Jun 30, 2025
Pentwater Capital Management LP
815.00K
2.06%
-183.75K
-18.40%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Global X Russell 2000 Covered Call ETF
Proporción0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
Proshares Ultra Russell 2000
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI